Literature DB >> 32556340

Eruptive Halo Naevi: A Possible Indicator of Malignant Disease in a Case Series of Post-Adolescent Patients.

Henrik F Lorentzen1.   

Abstract

Halo naevi are considered benign. They occur in children and adolescents. Eruptive multiple halo naevi are infrequently seen in adults. The first patient in this case series had previously had melanoma. Positron emission tomography-computed tomography (PET-CT) showed a papillary thyroid carcinoma. Subsequent adult patients underwent an examination programme similar to melanoma patients with unknown primary, including PET scanning. Sixteen patients were followed over a 6-year period. In total there were 2 papillary thyroid cancers, 1 neuroendocrine lung tumour, 1 patient had had lung metastases from a thin melanoma 7 years previously, 3 patients had primary cutaneous melanoma (1 had had halo naevi since excision of 2 melanomas 15 years previously) and 1 had melanoma metastasis with unknown primary. The incidence of melanoma was 955 times higher than expected (standardized incidence rate). The benefits of PET scanning must be validated in a controlled trial prior to implementation into clinical practice.

Entities:  

Keywords:  Sutton naevus; melanoma-associated hypopigmentation; neuroendocrine tumour; thyroid cancer; vitiligo; halo naevus

Mesh:

Year:  2020        PMID: 32556340      PMCID: PMC9207645          DOI: 10.2340/00015555-3568

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  24 in total

1.  Typical halo nevi in childhood: is a biopsy necessary? Yes, but perhaps from the duodenum!

Authors:  Lars Marthinsen; Nils Osten Nilsson
Journal:  J Pediatr       Date:  2005-10       Impact factor: 4.406

Review 2.  Melanoma-associated leukoderma - immunology in black and white?

Authors:  Hadas Prag Naveh; Uma N M Rao; Lisa H Butterfield
Journal:  Pigment Cell Melanoma Res       Date:  2013-10-09       Impact factor: 4.693

Review 3.  The origin of neuroendocrine tumors and the neural crest saga.

Authors:  Juan Rosai
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

Review 4.  Bystander activation and autoimmunity.

Authors:  Yovana Pacheco; Yeny Acosta-Ampudia; Diana M Monsalve; Christopher Chang; M Eric Gershwin; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2019-07-17       Impact factor: 7.094

Review 5.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

6.  Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Authors:  R Michael Tuttle; James A Fagin; Gerald Minkowitz; Richard J Wong; Benjamin Roman; Snehal Patel; Brian Untch; Ian Ganly; Ashok R Shaha; Jatin P Shah; Mark Pace; Duan Li; Ariadne Bach; Oscar Lin; Adrian Whiting; Ronald Ghossein; Inigo Landa; Mona Sabra; Laura Boucai; Stephanie Fish; Luc G T Morris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-10-01       Impact factor: 6.223

7.  Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.

Authors:  Andrea Paradisi; Stefano Tabolli; Biagio Didona; Luciano Sobrino; Nicoletta Russo; Damiano Abeni
Journal:  J Am Acad Dermatol       Date:  2014-09-19       Impact factor: 11.527

8.  Increased melanoma risk in individuals with papillary thyroid carcinoma.

Authors:  Gretchen M Oakley; Karen Curtin; Lester Layfield; Elke Jarboe; Luke O Buchmann; Jason P Hunt
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-05       Impact factor: 6.223

Review 9.  Vitiligo and Autoimmune Thyroid Disorders.

Authors:  Enke Baldini; Teresa Odorisio; Salvatore Sorrenti; Antonio Catania; Francesco Tartaglia; Giovanni Carbotta; Daniele Pironi; Roberta Rendina; Eleonora D'Armiento; Severino Persechino; Salvatore Ulisse
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-27       Impact factor: 5.555

10.  Dermoscopy is a new diagnostic tool in diagnosis of common hypopigmented macular disease: A descriptive study.

Authors:  Khitam Al-Refu
Journal:  Dermatol Reports       Date:  2018-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.